{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:57:50Z","timestamp":1778914670673,"version":"3.51.4"},"reference-count":36,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2017.00169","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T00:14:57Z","timestamp":1507680897000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":44,"title":["Selective Essential Oils from Spice or Culinary Herbs Have High Activity against Stationary Phase and Biofilm Borrelia burgdorferi"],"prefix":"10.3389","volume":"4","author":[{"given":"Jie","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanliang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevena","family":"Zubcevik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Miklossy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,10,11]]},"reference":[{"key":"B1","unstructured":"Lyme Disease2017"},{"key":"B2","doi-asserted-by":"publisher","first-page":"316","DOI":"10.7150\/ijms.14552","article-title":"Prevalence of the Lyme disease spirochete, Borrelia burgdorferi, in Blacklegged Ticks, Ixodes scapularis at Hamilton-Wentworth, Ontario","volume":"13","author":"Scott","year":"2016","journal-title":"Int J Med Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11136-012-0126-6","article-title":"Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?","volume":"22","author":"Aucott","year":"2013","journal-title":"Qual Life Res"},{"key":"B5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/JCM.35.1.111-116.1997","article-title":"Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment","volume":"35","author":"Straubinger","year":"1997","journal-title":"J Clin Microbiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1128\/AAC.01050-07","article-title":"Persistence of Borrelia burgdorferi following antibiotic treatment in mice","volume":"52","author":"Hodzic","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e86907","DOI":"10.1371\/journal.pone.0086907","article-title":"Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic treatment in mice","volume":"9","author":"Hodzic","year":"2014","journal-title":"PLoS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e29914","DOI":"10.1371\/journal.pone.0029914","article-title":"Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection","volume":"7","author":"Embers","year":"2012","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/cid\/cit939","article-title":"Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study","volume":"58","author":"Marques","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0140-6736(94)90130-9","article-title":"Lyme borreliosis: basic science and clinical aspects","volume":"343","author":"Pfister","year":"1994","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1471-2334-12-173","article-title":"Probable late Lyme disease: a variant manifestation of untreated Borrelia burgdorferi infection","volume":"12","author":"Aucott","year":"2012","journal-title":"BMC Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.amjmed.2013.02.014","article-title":"Treatment trials for post-Lyme disease symptoms revisited","volume":"126","author":"Klempner","year":"2013","journal-title":"Am J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"18656","DOI":"10.1073\/pnas.0908236106","article-title":"Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecycline","volume":"106","author":"Brorson","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1038\/emi.2014.53","article-title":"Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library","volume":"3","author":"Feng","year":"2014","journal-title":"Emerg Microb Infect"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0117207","DOI":"10.1371\/journal.pone.0117207","article-title":"Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline","volume":"10","author":"Feng","year":"2015","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6288","DOI":"10.1128\/AAC.00883-15","article-title":"Persister development by Borrelia burgdorferi populations in vitro","volume":"59","author":"Caskey","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1128\/AAC.00864-15","article-title":"Borrelia burgdorferi, the causative agent of Lyme disease, forms drug-tolerant persister cells","volume":"59","author":"Sharma","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1038\/emi.2015.31","article-title":"Identification of new compounds with high activity against stationary phase Borrelia burgdorferi from the NCI compound collection","volume":"4","author":"Feng","year":"2015","journal-title":"Emerg Microbes Infect"},{"key":"B19","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3389\/fmicb.2016.00743","article-title":"A drug combination screen identifies drugs active against amoxicillin-induced round bodies of in vitro Borrelia burgdorferi persisters from an FDA drug library","volume":"7","author":"Feng","year":"2016","journal-title":"Front Microbiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3390\/ph6121451","article-title":"Effect of essential oils on pathogenic bacteria","volume":"6","author":"Nazzaro","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1691\/ph.2010.9762","article-title":"Growth inhibiting activity of volatile oil from Cistus creticus L. against Borrelia burgdorferi s.s. in vitro","volume":"65","author":"Hutschenreuther","year":"2010","journal-title":"Pharmazie"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e111809","DOI":"10.1371\/journal.pone.0111809","article-title":"An optimized SYBR Green I\/PI assay for rapid viability assessment and antibiotic susceptibility testing for Borrelia burgdorferi","volume":"9","author":"Feng","year":"2014","journal-title":"PLoS One"},{"key":"B23","volume-title":"The United States Pharmacopeia","year":"2000"},{"key":"B24","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement","author":"Wikler","year":"2005"},{"key":"B25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fmicb.2016.00062","article-title":"Eradication of biofilm-like microcolony structures of Borrelia burgdorferi by daunomycin and daptomycin but not mitomycin c in combination with doxycycline and cefuroxime","volume":"7","author":"Feng","year":"2016","journal-title":"Front Microbiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1089\/jmf.2013.0079","article-title":"Essential oil composition and antibacterial activity of Origanum vulgare subsp. glandulosum Desf. at different phenological stages","volume":"16","author":"Bejaoui","year":"2013","journal-title":"J Med Food"},{"key":"B27","doi-asserted-by":"publisher","first-page":"212","DOI":"10.5455\/jice.20160331064446","article-title":"In vitro antimicrobial activity of five essential oils on multidrug resistant Gram-negative clinical isolates","volume":"5","author":"Sakkas","year":"2016","journal-title":"J Intercult Ethnopharmacol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1002\/jsfa.3358","article-title":"In vitro degradation and in vivo passage kinetics of carvacrol, thymol, eugenol and trans-cinnamaldehyde along the gastrointestinal tract of piglets","volume":"88","author":"Michiels","year":"2008","journal-title":"J Sci Food Agric"},{"key":"B29","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1080\/19440049.2017.1285056","article-title":"Pharmacokinetic analysis of thymol, carvacrol and diallyl disulfide after intramammary and topical applications in healthy organic dairy cattle","volume":"34","author":"Mason","year":"2017","journal-title":"Food Addit Contam Part A Chem Anal Control Expo Risk Assess"},{"key":"B30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/FBP.0b013e3283534301","article-title":"Cognitive-enhancing activity of thymol and carvacrol in two rat models of dementia","volume":"23","author":"Azizi","year":"2012","journal-title":"Behav Pharmacol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3233\/JAD-2004-6608","article-title":"Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease","volume":"6","author":"Miklossy","year":"2004","journal-title":"J Alzheimers Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1472-8206.2010.00850.x","article-title":"Antidepressant-like effect of carvacrol (5-isopropyl-2-methylphenol) in mice: involvement of dopaminergic system","volume":"25","author":"Melo","year":"2011","journal-title":"Fundam Clin Pharmacol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.actatropica.2016.09.001","article-title":"In vitro and in vivo efficacy of carvacrol against Echinococcus granulosus","volume":"164","author":"Fabbri","year":"2016","journal-title":"Acta Trop"},{"key":"B34","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0278-6915(99)00075-7","article-title":"Toxicity of selected plant volatiles in microbial and mammalian short-term assays","volume":"37","author":"Stammati","year":"1999","journal-title":"Food Chem Toxicol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"690","DOI":"10.4149\/neo_2014_084","article-title":"Carvacrol and rosemary essential oil manifest cytotoxic, DNA-protective and pro-apoptotic effect having no effect on DNA repair","volume":"61","author":"Melusova","year":"2014","journal-title":"Neoplasma"},{"key":"B36","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/tox.20380","article-title":"The in vivo genotoxic effects of carvacrol and thymol in rat bone marrow cells","volume":"23","author":"Azirak","year":"2008","journal-title":"Environ Toxicol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00169\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T07:11:46Z","timestamp":1603091506000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00169\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,11]]},"references-count":36,"alternative-id":["10.3389\/fmed.2017.00169"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2017.00169","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/130898","asserted-by":"object"}]},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,11]]},"article-number":"169"}}